Patents-Review.com
🔗 Permalink
Inventor profile of:

Daniel R. GETTS

City:

Northbrook, Illinois

Country:

United States

Published Applications:

23

Last publication date:

2024-07-25

Top Assignees for applications by Daniel R. GETTS

The entities that hold a legal rights for patent applications filed by inventor GETTS Daniel R.:

Recent patent applications by GETTS Daniel R.

Daniel R. GETTS from Northbrook, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-25
US20240245719A1
Human necessities

MODIFIED IMMUNE-MODULATING PARTICLES

 #2 | 2024-04-18
US20240122864A1
Human necessities

PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES

 #3 | 2024-01-04
US20240000830A1
Human necessities

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #4 | 2022-09-01
US20220273778A1
Human necessities

METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE

 #5 | 2022-05-12
US20220143160A1
Human necessities

Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance

 #6 | 2022-01-13
US20220008523A1
Human necessities

PEPTIDE CONJUGATED PARTICLES

 #7 | 2022-01-06
US20220000994A1
Human necessities

Peptide conjugated particles

 #8 | 2021-09-23
US20210290558A1
Human necessities

Process for the preparation of tolerizing immune-modulating particles

 #9 | 2021-02-04
US20210030892A1
Human necessities

TREATMENT OF CELIAC DISEASE WITH TOLERIZING PARTICLES

 #10 | 2021-01-07
US20210000932A1
Human necessities

Peptide Conjugated Particles

 #11 | 2020-10-29
US20200338116A1
Human necessities

MODIFIED IMMUNE-MODULATING PARTICLES

 #12 | 2020-10-22
US20200330569A1
Human necessities

Peptide conjugated particles

 #13 | 2020-10-08
US20200316181A1
Human necessities

Peptide conjugated particles

 #14 | 2020-09-03
US20200276228A1
Human necessities

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #15 | 2020-09-03
US20200276227A1
Human necessities

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #16 | 2020-02-13
US20200046816A1
Human necessities

Compositions and Methods for Antigen-Specific Tolerance

 #17 | 2019-12-05
US20190365877A1
Human necessities

Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance

 #18 | 2019-09-19
US20190282707A1
Human necessities

Covalent polymer-antigen conjugated particles

 #19 | 2019-08-29
US20190262441A1
Human necessities

Peptide conjugated particles for the treatment of inflammation

 #20 | 2019-02-28
US20190060354A1
Human necessities

Immune-modifying nanoparticles for the treatment of inflammatory diseases

 #21 | 2018-09-27
US20180271962A1
Human necessities

Peptide conjugated particles

 #22 | 2017-11-02
US20170312349A1
Human necessities

Peptide conjugated particles

 #23 | 2017-06-22
US20170173071A1
Human necessities

Immune-modifying nanoparticles for the treatment of inflammatory diseases
InventorID:

1907022 ⎘